Bestchrom Highlights Cost-Efficient Purification Solutions at BIOPLUS-INTERPHEX KOREA 2025

Oct 21,2025

Bestchrom

SEOUL, South Korea — October 15–17, 2025 — Bestchrom participated in BIOPLUS-INTERPHEX KOREA 2025, where the company engaged with industry experts and innovative enterprises from around the world to explore new pathways for innovation and development in the biopharmaceutical industry.

Event Highlights

During the exhibition, Bestchrom presented a comprehensive range of cost-effective purification solutions for antibodies, vaccines, recombinant proteins, and plasmids. Its high-performance products attracted strong interest from pharmaceutical manufacturers, biotechnology companies, and CRO/CDMOs. The Bestchrom team held in-depth discussions with numerous prospective customers and partners, providing application-oriented solutions tailored to real process needs and earning wide recognition and positive feedback.

Highlights in Focus

Among the exhibits, Bestchrom’s next-generation alkaline-tolerant recombinant Protein A affinity resin -- AT Protein A Diamond Ultra -- stood out for its high dynamic binding capacity (DBC), excellent alkaline tolerance, low backpressure, fast flow rate, and consistent lot-to-lot performance, becoming a highlight on the show floor.

Bestchrom’s participation in BIOPLUS-INTERPHEX KOREA 2025 marks another step forward in its global expansion. Moving forward, the company will continue to enhance its overseas strategy, strengthen its technical capabilities, and deliver more efficient and economical purification solutions to help biopharmaceutical manufacturers worldwide overcome process bottlenecks and accelerate production efficiency.

Bestchrom Bioscience, creates value via effective purification solution.